Thursday, Jun 26, 2014
Botox gained global recognition through its use as a wrinkle-eraser for Hollywood stars, and quickly became a must-have for Americans seeking to find an alternative to the undiscovered fountain of youth. However, 25 years after hitting the U.S. market, Botox’s revenues continue to climb, and the uses have nothing to do with vanity.
Fifty-four percent of the muscle paralyzing drug’s sales include treatment for chronic migraine, overactive bladder, Juvenile Cerebral Palsy, upper limb spasticity, Cervical Dystonia, crossed eyes, pain in the joints and severe underarm sweating.
Harbin Clinic Neurologists Dr. Jeffrey Glass, Dr. David Hale, Dr. Brian Hard and Dr. Jay Schecter have had success in Botox treatments for patients who suffer from Cervical Dystonia (twisting of the neck due to tight/overactive muscles), Cerebral Palsy, refractory migraine and upper limb spasticity. “Botox is made from a botulinum toxin, a type of nerve poison created by bacteria. When injected in very small, targeted doses, the drug temporarily paralyzes the involved muscles to improve range of motion and relieve pain,” said Harbin Clinic Neurologist and Neurology Department Chairman, Dr. David Hale.
In 2013, the drug reached $2 billion in revenue sales, seeing a nine percent increase from 2012 sales. As stated recently in The Wall Street Journal, “Projections by analysts at Sterne Agee & Leach Inc. show the drug to rise to $3.15 billion in global sales by 2018.
For more information on the uses of Botox for neurological disorders, or to schedule an appointment with a Harbin Clinic neurologist, call 762-235-3600 or visit Harbin Clinic Neurology